Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1973 Jul;52(7):1616–1619. doi: 10.1172/JCI107339

Metabolism and Excretion of Exogenous Thyrotropin-Releasing Hormone in Humans

Rahim M Bassiri 1, Robert D Utiger 1
PMCID: PMC302433  PMID: 4198107

Abstract

To study the metabolism of thyrotropin-releasing hormone (TRH) in vivo, 400 μg TRH was administered intravenously to eight normal male subjects. Multiple plasma and urine samples were obtained before and after TRH administration. Serum TSH concentrations increased after TRH administration in all subjects. Plasma TRH levels, measured by radioimmunoassay, were undetectable (< 0.4 ng/ml) before TRH administration. Plasma TRH concentrations averaged 33±7 ng/ml (mean ±SEM) 2 min after TRH injection. Thereafter, they decreased rapidly so that the mean plasma TRH level was 2.9 ng/ml 20 min after TRH administration. The fall in plasma TRH levels was linear during this interval. Thereafter TRH levels declined more slowly. The mean half-life (t½) of TRH was 5.3±0.5 min. The mean distribution volume was 15.7±3.8 liters, an average of 16.5% of body weight in these subjects. In the urine, 5.5±0.9% of the administered TRH was recovered in the 3 h after TRH administration. Of the total urinary TRH recovered, 84.9% was excreted in the first 30 min. These results indicate that TRH is distributed in a large volume, that it is rapidly metabolized and that a significant quantity of administered TRH is excreted in the urine.

Full text

PDF
1616

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson M. S., Bowers C. Y., Kastin A. J., Schalch D. S., Schally A. V., Snyder P. J., Utiger R. D., Wilber J. F., Wise A. J. Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man. N Engl J Med. 1971 Dec 2;285(23):1279–1283. doi: 10.1056/NEJM197112022852302. [DOI] [PubMed] [Google Scholar]
  2. Bassiri R., Utiger R. D. Serum inactivation of the immunological and biological activity of thyrotropin releasing hormone (TRH). Endocrinology. 1972 Sep;91(3):657–664. doi: 10.1210/endo-91-3-657. [DOI] [PubMed] [Google Scholar]
  3. EDELMAN I. S., LEIBMAN J. Anatomy of body water and electrolytes. Am J Med. 1959 Aug;27:256–277. doi: 10.1016/0002-9343(59)90346-8. [DOI] [PubMed] [Google Scholar]
  4. Leppaluoto J., Virkkunen P., Lybeck H. Elimination of TRH in man. J Clin Endocrinol Metab. 1972 Sep;35(3):477–478. doi: 10.1210/jcem-35-3-477. [DOI] [PubMed] [Google Scholar]
  5. Lieblich J., Utiger R. D. Triiodothyronine radioimmunoassay. J Clin Invest. 1972 Jan;51(1):157–166. doi: 10.1172/JCI106786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MURPHY B. E., PATTEE C. J. DETERMINATION OF THYROXINE UTILIZING THE PROPERTY OF PROTEIN-BINDING. J Clin Endocrinol Metab. 1964 Feb;24:187–196. doi: 10.1210/jcem-24-2-187. [DOI] [PubMed] [Google Scholar]
  7. Nair R. M., Redding T. W., Schally A. V. Site of inactivation of thyrotropin-releasing hormone by human plasma. Biochemistry. 1971 Sep 14;10(19):3621–3624. doi: 10.1021/bi00795a021. [DOI] [PubMed] [Google Scholar]
  8. Odell W. D., Wilber J. F., Utiger R. D. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res. 1967;23:47–85. doi: 10.1016/b978-1-4831-9826-2.50005-2. [DOI] [PubMed] [Google Scholar]
  9. Redding T. W., Schally A. V. Studies on the inactivation of thyrotropin-releasing hormone (TRH). Proc Soc Exp Biol Med. 1969 Jun;131(2):415–420. doi: 10.3181/00379727-131-33891. [DOI] [PubMed] [Google Scholar]
  10. Redding T. W., Schally A. V. The distribution of radioactivity following the administration of labeled thyrotropin-releasing hormone (TRH) in rats and mice. Endocrinology. 1971 Oct;89(4):1075–1081. doi: 10.1210/endo-89-4-1075. [DOI] [PubMed] [Google Scholar]
  11. Snyder P. J., Utiger R. D. Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab. 1972 Feb;34(2):380–385. doi: 10.1210/jcem-34-2-380. [DOI] [PubMed] [Google Scholar]
  12. Vale W. W., Burgus R., Dunn T. F., Guillemin R. In vitro plasma inactivation of thyrotropin releasing factor (TRF) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-His-OME. Hormones. 1971;2(4):193–203. doi: 10.1159/000178234. [DOI] [PubMed] [Google Scholar]
  13. York D. A., Hershman J. M., Utiger R. D., Bray G. A. Thyrotropin secretion in genetically obese rats. Endocrinology. 1972 Jan;90(1):67–72. doi: 10.1210/endo-90-1-67. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES